Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole

被引：2

作者：

Calabro, Maria Luisa ^{[1
]}

Caputo, Rosanna ^{[1
]}

Ettari, Roberta ^{[2
]}

Puia, Giulia ^{[3
]}

Ravazzini, Federica ^{[3
]}

Zappala, Maria ^{[1
]}

Micale, Nicola ^{[1
]}

机构：

[1] Univ Messina, Dipartimento Sci Farmaco & Prod Salute, I-98168 Messina, Italy

[2] Univ Milan, Dipartimento Sci Farmaceut, I-20133 Milan, Italy

[3] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, Reggio Emilia, Italy

来源：

MEDICINAL CHEMISTRY RESEARCH | 2013年 / 22卷 / 12期

关键词：

2-Aminobenzoxazole derivatives; Riluzole; Patch-clamp technique; Neuronal primary cultures; Binding assays; AMYOTROPHIC-LATERAL-SCLEROSIS; NEURONS; SODIUM; MECHANISMS; RECEPTORS; GLUTAMATE; RELEASE; TRIAL; NMDA;

D O I：

10.1007/s00044-013-0594-4

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This manuscript describes the synthesis of a new series of 2-amino-6-(trifluoromethoxy)benzoxazole derivatives (1-5) and a benzothiazine derivative (6) structurally related to riluzole, the only neuroprotective drug currently approved for the treatment of the amyotrophic lateral sclerosis. Preliminary results indicate that the synthesized compounds, in particular benzamide derivatives 3 and 4, are able to antagonize voltage-dependent Na+ channel currents, and therefore they could be exploited as new inhibitors of these channels. Moreover, all compounds possess low binding affinity for GABA and NMDA receptors.

引用

页码：6089 / 6095

页数：7

共 24 条

[1]

Anzini M., 2009, [No title captured], Patent No. [WO 2009/040331, 2009040331, WO 2009/040331A2]

[2] Do sodium channel blockers have neuroprotective effect after onset of ischemic insult? [J].

Ates, Ozkan ;

Cayli, Suleyman R. ;

Gurses, Iclal ;

Karabulut, Aysun Bay ;

Yucel, Neslihan ;

Kocak, Ayhan ;

Cakir, Celal Ozbek ;

Yologlu, Saim .

NEUROLOGICAL RESEARCH, 2007, 29 (03) :317-323

[3] A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].

BENSIMON, G ;

LACOMBLEZ, L ;

MEININGER, V ;

BOUCHE, P ;

DELWAIDE, C ;

COURATIER, P ;

BLIN, O ;

VIADER, F ;

PEYROSTPAUL, H ;

DAVID, J ;

MALOTEAUX, JM ;

HUGON, J ;

LATERRE, EC ;

RASCOL, A ;

CLANET, M ;

VALLAT, JM ;

DUMAS, A ;

SERRATRICE, G ;

LECHEVALLIER, B ;

PEUCH, AJ ;

NGUYEN, T ;

SHU, C ;

BASTIEN, P ;

PAPILLON, C ;

DURRLEMAN, S ;

LOUVEL, E ;

GUILLET, P ;

LEDOUX, L ;

ORVOENFRIJA, E ;

DIB, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591

[4] Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents [J].

Caputo, Rosanna ;

Calabro, Maria Luisa ;

Micale, Nicola ;

Schimmer, Aaron D. ;

Ali, Moshin ;

Zappala, Maria ;

Grasso, Silvana .

MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (09) :2644-2651

[5] NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice [J].

De Sarro, G ;

Siniscalchi, A ;

Ferreri, G ;

Gallelli, L ;

De Sarro, A .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 408 (01) :25-34

[6] The pharmacology and mechanism of action of riluzole [J].

Doble, A .

NEUROLOGY, 1996, 47 (06) :S233-S241

[7] 2-Substituted tryptamines:: Agents with selectivity for 5-HT6 serotonin receptors [J].

Glennon, RA ;

Lee, M ;

Rangisetty, JB ;

Dukat, M ;

Roth, BL ;

Savage, JE ;

McBride, A ;

Rauser, L ;

Hufeisen, S ;

Lee, DKH .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (05) :1011-1018

[8]

Greeson J, 2009, U.S. Patent, Patent No. [2009/0286876, 20090286876]

[9] IMPROVED PATCH-CLAMP TECHNIQUES FOR HIGH-RESOLUTION CURRENT RECORDING FROM CELLS AND CELL-FREE MEMBRANE PATCHES [J].

HAMILL, OP ;

MARTY, A ;

NEHER, E ;

SAKMANN, B ;

SIGWORTH, FJ .

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1981, 391 (02) :85-100

[10] Neuroprotective agent riluzole potentiates postsynaptic GABAA receptor function [J].

He, Y ;

Benz, A ;

Fu, T ;

Wang, M ;

Covey, DF ;

Zorumski, CF ;

Mennerick, S .

NEUROPHARMACOLOGY, 2002, 42 (02) :199-209

← 1 2 3 →